Cytokinetics | CYTK - Ebit



Cytokinetics reported $-111506000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
Bayer EUR -36000000 2.95B Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Cytokinetics USD -111506000 44.12M Jun/2025
Eisai JPY 20.74B 1.77B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Exelixis USD 215.68M 28.82M Jul/2025
Geron USD -12454000 4.25M Jun/2025
Halozyme Therapeutics USD 202.44M 54.09M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
Ligand Pharmaceuticals USD 43.56M 92.88M Jun/2025
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Regeneron Pharmaceuticals USD 1.52B 608.6M Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Sanofi EUR 1.51B 1.39B Jun/2025